WENTWORTH KORY JAMES
Chief Financial Officer
WENTWORTH KORY JAMES has filed 7 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.
On the most recent filing, WENTWORTH KORY JAMES is listed as Chief Financial Officer at Entrada Therapeutics, Inc. Inside the rolling window, WENTWORTH KORY JAMES reported no open-market purchases and 5 open-market sales totaling $434K in TRDA. The largest disclosed transaction in the window is a sale of 11,388 TRDA shares on Mar 10, 2026, worth $148K.
Companies traded
Other insiders at TRDA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$434K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has WENTWORTH KORY JAMES made?
WENTWORTH KORY JAMES has filed 7 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.
Which companies does WENTWORTH KORY JAMES trade?
WENTWORTH KORY JAMES has filed SEC Form 4 disclosures for 1 company, including TRDA.
When was WENTWORTH KORY JAMES's most recent SEC Form 4 filing?
WENTWORTH KORY JAMES's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.
What is WENTWORTH KORY JAMES's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, WENTWORTH KORY JAMES is listed as Chief Financial Officer.
What is WENTWORTH KORY JAMES's total buy and sell value in the current window?
Inside the rolling retention window, WENTWORTH KORY JAMES bought $0 and sold $434K based on SEC Form 4 filings.
What was WENTWORTH KORY JAMES's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 11,388 TRDA shares on 2026-03-10, worth $148K, per SEC Form 4 filings.